Find information on thousands of medical conditions and prescription drugs.

Desipramine

Desipramine is a tricyclic antidepressant (TCA) that inhibits the reuptake of norepinephrine. It is sold under the brand names Norpramin® and Pertofrane®. It is used to treat depression, but not considered a first line treatment since the introduction of SSRI antidepressants. Desipramine is an active metabolite of imipramine. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Along with other tricyclics, desipramine has found use in treating neuropathic pain. The mechanism of action seems to involve the activation, through norepinephrine reuptake inhibition, of descending pathways in the spinal cord that block pain signals from ascending to the brain. Desipramine is one of the most potent and selective medications in this respect.

Some evidence suggests that desipramine may help with ADD, and along with Wellbutrin, the only serotonergic drug that is documented for this condition.

Read more at Wikipedia.org


[List your site here Free!]


Quetiapine overdose induced acute respiratory distress syndrome
From CHEST, 10/1/05 by Paul Strachan

INTRODUCTION: A 41 year-old male, with bipolar disorder presented after ingestion of 4500 mg of quetiapine. Within 24 hours, respiratory failure ensued, requiring intubation and mechanical ventilation. Chest radiograph demonstrated bilateral infiltrates, consistent with Acute Respiratory Distress Syndrome (ARDS).

CASE PRESENTATION: The patient is a 41-year old male with a history of bipolar disorder and generalized anxiety. He was recently admitted to another hospital with depression and suicidal ideation. Discharge medications included: quetiapine 25 mg twice daily, valproic acid, gabapentin, desipramine and paroxetine. Two days post-discharge, his parents observed clonic movements that were presumed to be seizures. Intravenous lorazepam was administered by EMS with no response. A suicide note was found next to an empty bottle of quetiapine that previously contained 180, 25 mg tablets. On examination: Vitals: HR 98, RR 20, BP 100/60, T 97.2 F. 02 Sat 100%. HEENT: Minimally reactive pupils, bilateral opsoclonus. Lungs: Poor inspiratory effort, otherwise clear. Heart: Regular rate & rhythm. Abdominal: Normal active bowel sounds, soft, non-tender. Extremities: No edema, clubbing or cyanosis. Neurological: Drowsy, but arousable to stimuli. Glasgow Coma Scale = 8. Frequent myncolonic jerks in all extremities. Chest radiograph: Minimally increased interstitial markings (Fig 1). ECG: Sinus Rhythm at 98 bpm. QT/QTc interval was prolonged at 536/684. EEG: No epileptiform activity. Toxicology: Positive for tricyclic antidepressants (TCA). Gas chromatography showed desipramine and quetiapine (quantitative levels were not available). Valproic acid level: 22 (ref 50-120). He received intravenous lorazepam, magnesium and sodium bicarbonate for electrocardiographic changes and was admitted to the intensive care unit (ICU). During the first twenty-four hours, the patient developed progressive hypoxemia, unresponsive to increased oxygen supplementation. There was no witnessed aspiration. He was intubated for hypoxemic respiratory failure. Post-intubation, he required 100% FIO2 and high levels of positive end-expiratory pressure (PEEP). Chest radiograph showed bilateral infiltrates (Fig 2). Central venous pressure (CVP) measured 10 cmH2O. Echocardiogram showed normal left ventricular function. The patient had a prolonged ICU course, complicated by the subsequent development of gram-negative bacteremia. After five weeks of mechanical ventilation, he improved clinically and was extubated. Once stable, he was transferred to psychiatry for further care.

[FIGURES 1-2 OMITTED]

DISCUSSIONS: Quetiapine fumarate is an antipsychotic drug that is an antagonist at multiple receptors in the brain including: serotonin, dopamine, adrenergic and histamine. Compared to older antipsychotic medications, it has an improved safety profile, particularly decreased extrapyramidal symptoms and tardive dyskinesia, although there is still a risk for neuroleptic malignant syndrome. (1) This patient developed progressive hypoxia with infiltrates, requiring mechanical ventilation within 24 hours of presentation. Respiratory depression has previously been seen with large ingestions of quetiapine. In a case series by Balit, four of eighteen patients with quetiapine overdose required mechanical ventilation. No patients developed ARDS. Our patient presented with minimal changes on his initial chest x-ray. Within 24 hours he had bilateral infiltrates and was intubated for respiratory failure. He required 100% FIO2 while on the ventilator, with an initial PaO2:FIO2 ratio of 90. The CVP was 10 mmHg and the ejection fraction was normal. These findings are all consistent with the diagnosis of ARDS. This is the first reported case of such resulting from quetiapine overdose.

CONCLUSION: As quetiapine is a relatively new medication, experience with cases of overdose are limited. This patient's respiratory status rapidly declined over the first twenty-four hours. Cases involving quetiapine overdose warrant admission, with close monitoring of respiratory status.

REFERENCE:

(1) Mosbey Drug Consult 2004 2 Balit C. et al. Quetiapine Poisoning: A Case Series. 2003 Annals of Emergency Medicine 42:6 751-758

DISCLOSURE: Paul Strachan, None.

Paul Strachan MD * Brian Benoff MD Long Island Jewish Medical Center, New Hyde Park, NY

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Desipramine
Home Contact Resources Exchange Links ebay